findmyKOL
Clinical trialNCT06526923RecruitingPhase 1/PHASE2Interventional

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

SponsorSpirovant Sciences, Inc.Enrollment15Cystic Fibrosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Kansas Medical Center

    Kansas City, Kansas, United States

    Joel Mermis
    Recruiting
  • Boston Children'S Hospital, Brigham & Women'S Hospital

    Boston, Massachusetts, United States

    Ahmet Uluer
    Recruiting
  • Columbia University

    New York, New York, United States

    Claire Keating
    Recruiting
  • Hospital at University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Daniel Dorgan
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Sept 2024
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
25 Nov 2024
Registered enrollment
15
Registry id
NCT06526923
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.